Yayınlanmış 1 Ocak 2020
| Sürüm v1
Dergi makalesi
Açık
Neuroinflammation Mediators are Reduced in Sera of Parkinson's Disease Patients with Mild Cognitive Impairment
Oluşturanlar
- 1. Demiroglu Bilim Univ, Fac Med, Dept Physiol, Istanbul, Turkey
- 2. Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Neurosci, Istanbul, Turkey
- 3. Istanbul Univ, Neuroimaging Unit, Hulusi Behcet Life Sci Res Lab, Istanbul, Turkey
- 4. Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey
- 5. Bogazici Univ, Biomed Engn Inst, Istanbul, Turkey
Açıklama
Introduction: Cognitive impairment is common in Parkinson's disease (PD) and PD patients with mild cognitive impairment (PD-MCI) are at increased risk of developing Parkinson's disease dementia (PDD). Reliable biomarkers are required for objective identification of cognitive decline in PD. In this pilot study, serum levels of well-known mediators of neuroinflammation were measured in PD patients with or without MCI to find out the involvement of neuroinflammation and microglial activation in PD-MCI.
Dosyalar
bib-2320807a-f281-4325-81c6-7ccac0f7ffd9.txt
Dosyalar
(291 Bytes)
| Ad | Boyut | Hepisini indir |
|---|---|---|
|
md5:07935ccba6b207c209aaf33988b83b30
|
291 Bytes | Ön İzleme İndir |